Statute Details
- Title: Health Products (Supply of Medical Devices — Exemption) Order 2022
- Act Code: HPA2007-S688-2022
- Legislation Type: Subsidiary Legislation (SL)
- Authorising Act: Health Products Act 2007
- Enacting Power: Section 70 of the Health Products Act 2007
- Commencement: 1 September 2022
- SL Number: S 688/2022
- Status: Current version as at 27 March 2026
- Key Provisions: Section 1 (citation and commencement), Section 2 (retail supply exemption), Section 3 (revocation)
- Made Date: 12 August 2022
- Maker: Health Sciences Authority (Chairperson: Benjamin Ong)
What Is This Legislation About?
The Health Products (Supply of Medical Devices — Exemption) Order 2022 (“the Order”) is a targeted regulatory instrument under Singapore’s Health Products Act 2007. In plain terms, it creates a limited exemption from a specific statutory requirement relating to the supply of medical devices by retail.
At its core, the Order addresses how certain categories of medical devices may be supplied to the public through retail channels. It does so by carving out an exemption for particular devices that were imported before the Order’s commencement date (1 September 2022). This means that, for those devices, a retail supplier does not have to comply with the relevant requirement in section 15(1) of the Health Products Act 2007—at least to the extent the exemption applies.
The Order also performs a “cleanup” function: it revokes an earlier exemption order (the 2020 exemption order) so that the regulatory framework remains coherent and up to date. For practitioners, this revocation is important because it determines which exemption regime applies at different points in time, and therefore affects compliance advice and risk assessment.
What Are the Key Provisions?
Section 1: Citation and commencement provides the formal identification and timing of the Order. It states that the Order is the “Health Products (Supply of Medical Devices — Exemption) Order 2022” and that it comes into operation on 1 September 2022. For legal compliance, commencement dates matter because the exemption is expressly tied to whether the medical devices were imported before that date.
Section 2: Exemption in relation to supply by retail is the principal operative provision. It states that section 15(1) of the Health Products Act 2007 does not apply to the supply by retail by a person of any of the following medical devices imported before 1 September 2022:
(a) a particulate respirator;
(b) any protective gear;
(c) a surgical mask;
(d) a thermometer for measuring human body temperature.
In practical terms, section 2 creates a transitional compliance relief for retail supply of specified health-related devices that were already in the supply chain (imported before the cut-off date). The legal effect is that the retail supplier can supply those devices without the section 15(1) requirement being applied to them, provided the devices fall within the listed categories and the import timing requirement is satisfied.
Interpreting “imported before 1 September 2022” is likely to be a key compliance question. The exemption is not based on when the device is manufactured, when it is purchased by the retailer, or when it is first offered for sale. It is based on importation. Accordingly, practitioners advising retailers, distributors, or compliance teams should focus on documentary evidence of import dates (for example, import declarations, customs records, and shipping documents) to support that the devices qualify for the exemption.
Section 3: Revocation provides that the Health Products (Import, Wholesale and Supply of Medical Devices — Exemption) Order 2020 (G.N. No. S 78/2020) is revoked. This means that the 2020 exemption regime no longer applies after the revocation takes effect (subject to how the revocation interacts with the commencement of the 2022 Order). For practitioners, revocation is not merely administrative; it affects the legal basis for any continued retail supply of exempt devices and may require a re-check of compliance positions taken under the 2020 Order.
Because the 2022 Order is expressly tied to devices imported before 1 September 2022, it also functions as a bridge from the earlier 2020 regime. The revocation indicates that the legislature intended to replace the earlier exemption framework with a new one that reflects the regulatory and public health context as of 2022.
How Is This Legislation Structured?
The Order is structured in a concise, three-section format:
Section 1 sets out the citation and commencement.
Section 2 creates the substantive exemption for retail supply of specified medical devices imported before the commencement date.
Section 3 revokes the earlier 2020 exemption order.
There are no additional parts or schedules in the extract provided, reflecting the Order’s narrow scope. The drafting style is typical of subsidiary legislation that is designed to make a specific regulatory adjustment without re-stating the broader framework of the parent Act.
Who Does This Legislation Apply To?
The exemption in section 2 applies to “supply by retail” by a person of the specified medical devices, provided those devices were imported before 1 September 2022. This language is broad and is not limited to a particular class of business entity. It can therefore capture retailers, importers who also sell retail, and other persons who offer the listed devices for sale to end users.
However, the exemption is not universal. It is limited to (i) the retail supply context, (ii) the specific device categories listed in the Order, and (iii) the import timing condition. Devices outside the listed categories, or devices imported on or after 1 September 2022, would not fall within the exemption and would remain subject to the general requirements of the Health Products Act 2007—specifically the requirement in section 15(1) to which the exemption refers.
Practitioners should also note that the Order addresses only the application of section 15(1) in the retail supply context. It does not, on its face, create exemptions for wholesale supply or importation unless those are addressed elsewhere (including in other subsidiary legislation). The revocation of the 2020 order suggests that the earlier regime may have covered broader activities, but the 2022 Order extract is focused on retail supply.
Why Is This Legislation Important?
This Order is important because it affects regulatory compliance obligations for a defined set of medical devices during a transitional period. For lawyers advising businesses in the health products supply chain, the Order provides a concrete basis to determine whether certain devices can be supplied by retail without the section 15(1) requirement being applied.
From a risk management perspective, the exemption reduces the compliance burden for retailers holding stock that entered Singapore before the cut-off date. This is particularly relevant for devices that were in high demand during the pandemic period and for which stock may have been imported earlier and distributed through retail channels over time.
At the same time, the Order’s narrow drafting means that compliance teams must be careful. The exemption is limited to specific device types—particulate respirators, protective gear, surgical masks, and human body thermometers—and to devices imported before 1 September 2022. If a retailer cannot substantiate import timing or if the device does not fall within the listed categories, reliance on the exemption could be misplaced, potentially exposing the business to regulatory enforcement risk under the Health Products Act 2007.
Finally, the revocation of the 2020 exemption order underscores the need for practitioners to check the current version and the timeline when advising. A business may have acted lawfully under the 2020 exemption regime for stock imported earlier, but the legal basis for continued supply after the new Order’s commencement may differ. The revocation ensures that the regulatory framework is not left in an inconsistent state.
Related Legislation
- Health Products Act 2007 (in particular, section 15(1) and the regulation-making power in section 70)
- Health Products (Import, Wholesale and Supply of Medical Devices — Exemption) Order 2020 (G.N. No. S 78/2020) — revoked by section 3 of this Order
Source Documents
This article provides an overview of the Health Products (Supply of Medical Devices — Exemption) Order 2022 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.